The Sanofi General Meeting was held on May 10, 2017 at the Palais des Congrès in Paris, France.
Documents related to the General Meeting
- Compte-rendu (in French)
- Voting Results
- Press release
- Specimen Voting Form (in French)
- Notice of Meeting (avis de convocation) published in BALO (in French)
- Notice of Meeting - General Meeting 2017
- Information available concerning the 2017 General Meeting (in French)
- Notice of meeting (avis de réunion) published in BALO (in French)
- Total number of voting rights and shares on March 15, 2017
Questions asked in writing
Preliminary remarks regarding questions in writing
As a reminder, any shareholder is entitled to ask questions in written to which the Board of Directors is bound to answer.
However, to be admissible, questions in writing must:
(i) relate to the agenda for the Shareholders' Meeting and not affect trade secrets ;
(ii) be sent to the Chairman by registered letter with acknowledgement of receipt or by electronic telecommunication at the address indicated in the notice of meeting no later than four business days before the Meeting;
(iii) be accompanied by a registration certificate either in the securities account held by Sanofi, or in bearer share accounts held by an intermediary.
The reply to a written question may be made at the Annual General Meeting and / or be published on our website (ww.sanofi.com, section ‘Investors / Financial Results & Events / General Meetings’), the French Commercial Code of Commerce providing that the answer to a question in writing is deemed to have been given when it appears on the company's website.
Furthermore, the questions may be summarized whenever their full wording is not necessary for their understanding, provided that their meaning is not altered.